Similar Search Results

Costo-efectividad consolidación de LMA pediátrica de riesgo intermedio en Colombia

García-Molina, Mario; Chicaíza-Becerra, Liliana Alejandra - In: COYUNTURA ECONÓMICA (2013)

transplantations, versus chemotherapy consolidation in pediatric patients with intermediate-risk acute myeloid leukemia. …

Persistent link: https://www.econbiz.de/10010945962

Finanziamento della Sanità - Limiti del PayGo e proposta di sistema multipilastro con Welfare Fund

Salerno, Nicola Carmine - Volkswirtschaftliche Fakultät, … - 2013

This paper describes the reasons at the basis of the insufficiency of pay-as-you-go systems to provide resources for financing health care in an ageing society with the low rates of growth that will characterise western industrialised economies during next decades. Intuitive arguments are...

Persistent link: https://www.econbiz.de/10011110379

Anatomy of crisis management: lessons from the infamous Toyota Case

Heller, Victor L.; Darling, John R. - In: European Business Review 24 (2012) 2, pp. 151-168

stages of a crisis – the preliminary (pre‐) crisis, acute crisis, chronic crisis, and crisis resolution. The present crisis … firm was thrust into an acute crisis that has now evolved into a chronic crisis. A brief overview of the historical …

Persistent link: https://www.econbiz.de/10014713421

Regional differences in health care of patients with inflammatory bowel disease in Germany

Lange, Ansgar; Prenzler, Anne; Bachmann, Frank Oliver; … - In: Health Economics Review 5 (2015) 29, pp. 1-11

Background: The regional availability of specialized physicians is an important aspect in healthcare of patients with IBD. The association between physician density and healthcare is not yet clear. Most studies did not consider district type, which reflects population density. Our research...

Persistent link: https://www.econbiz.de/10011599854

Regional differences in health care of patients with inflammatory bowel disease in Germany

Lange, Ansgar; Prenzler, Anne; Bachmann, Frank Oliver; … - In: Health economics review 5 (2015) 29, pp. 1-11

Persistent link: https://www.econbiz.de/10011472028

Should cost-effectiveness analysis include the cost of consumption activities? : an empirical investigation

Adarkwah, Charles Christian; Sadoghi, Amirhossein; … - In: Health economics 25 (2016) 2, pp. 249-256

Persistent link: https://www.econbiz.de/10011541426

Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany

Pöllinger, Bernadette; Schmidt, Wolfgang; Seiffert, Anna; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 2, pp. 195-203

Persistent link: https://www.econbiz.de/10012004819

Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom

Wilson, Michele R.; Bergman, Annika; Chevrou-Severac, Helene - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 229-240

Persistent link: https://www.econbiz.de/10011946252

The socio-economic impact of work disability due to inflammatory bowel disease in Brazil

Fróes, Renata de S. B.; Carvalho, Ana Teresa Pugas; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 463-470

Persistent link: https://www.econbiz.de/10011946902

Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn’s disease

Marchetti, Monia; Liberato, Nicola; Sabatino, Antonio; … - In: The European Journal of Health Economics 14 (2013) 6, pp. 853-861

TD is a cost-effective treatment in newly diagnosed CD patients with luminal moderate-to-severe disease, and sensitivity analysis showed the result to be robust. </AbstractSection> Copyright Springer-Verlag 2013

Persistent link: https://www.econbiz.de/10010993982

1
2
3
4
5
6
7
8
9
10
Next
Last